[go: up one dir, main page]

AT272530B - Verfahren zur Herstellung von neuen Thebain- und Oripavinderivaten - Google Patents

Verfahren zur Herstellung von neuen Thebain- und Oripavinderivaten

Info

Publication number
AT272530B
AT272530B AT571566A AT571566A AT272530B AT 272530 B AT272530 B AT 272530B AT 571566 A AT571566 A AT 571566A AT 571566 A AT571566 A AT 571566A AT 272530 B AT272530 B AT 272530B
Authority
AT
Austria
Prior art keywords
oripavin
thebaine
derivatives
new
production
Prior art date
Application number
AT571566A
Other languages
English (en)
Original Assignee
Reckitt And Sons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt And Sons Ltd filed Critical Reckitt And Sons Ltd
Application granted granted Critical
Publication of AT272530B publication Critical patent/AT272530B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT571566A 1965-06-15 1966-06-15 Verfahren zur Herstellung von neuen Thebain- und Oripavinderivaten AT272530B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
AT272530B true AT272530B (de) 1969-07-10

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT571566A AT272530B (de) 1965-06-15 1966-06-15 Verfahren zur Herstellung von neuen Thebain- und Oripavinderivaten

Country Status (14)

Country Link
AT (1) AT272530B (de)
BE (1) BE682551A (de)
BR (1) BR6680359D0 (de)
CH (1) CH558362A (de)
DE (1) DE1620206A1 (de)
DK (1) DK115926B (de)
ES (1) ES327925A1 (de)
FI (1) FI49724C (de)
FR (1) FR6395M (de)
GB (1) GB1136214A (de)
LU (1) LU51306A1 (de)
NL (1) NL6608255A (de)
NO (1) NO119590B (de)
SE (1) SE325276B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) * 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) † 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2614223A1 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CN102112479B (zh) * 2008-07-30 2014-10-29 普渡制药公司 丁丙诺啡类似物
US8293906B2 (en) 2008-09-30 2012-10-23 Mallinckrodt Llc Processes for the alkylation of norbuprenorphine with reduced impurity formation
NZ595591A (en) 2009-04-24 2013-11-29 Univ Brock Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
AU2012327247B2 (en) 2011-12-12 2015-12-24 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
CA2879942C (en) 2012-07-26 2020-06-02 Camurus Ab Opioid formulations
CN109010255B (zh) 2012-07-26 2022-10-21 卡姆拉斯公司 阿片样物质制剂
WO2014087226A1 (en) * 2012-12-07 2014-06-12 Purdue Pharma L.P. Buprenorphine analogs as opiod receptor modulators
PE20160002A1 (es) 2013-06-04 2016-01-23 Lohmann Therapie Syst Lts Sistema de liberacion transdermico
EP4448501A1 (de) 2021-12-16 2024-10-23 Arevipharma GmbH Verfahren zur herstellung von buprenorphin und vorläuferverbindungen davon

Also Published As

Publication number Publication date
SE325276B (de) 1970-06-29
BR6680359D0 (pt) 1973-12-26
FR6395M (de) 1968-10-21
NO119590B (de) 1970-06-08
NL6608255A (de) 1966-12-16
ES327925A1 (es) 1967-04-01
DK115926B (da) 1969-11-24
DE1620206A1 (de) 1970-03-19
CH558362A (de) 1975-01-31
FI49724C (fi) 1975-09-10
BE682551A (de) 1966-11-14
GB1136214A (en) 1968-12-11
LU51306A1 (de) 1966-08-16
FI49724B (de) 1975-06-02

Similar Documents

Publication Publication Date Title
AT279599B (de) Verfahren zur herstellung von neuen 3-furylmethanolen
AT277475B (de) Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten
AT272530B (de) Verfahren zur Herstellung von neuen Thebain- und Oripavinderivaten
CH478785A (de) Verfahren zur Herstellung von neuen Derivaten des Desglucohellebrins
AT267543B (de) Verfahren zur Herstellung von neuen substituierten Harnstoffderivaten
AT280472B (de) Verfahren zur Herstellung von neuen Penicillinen
AT276421B (de) Verfahren zur Herstellung von neuen 4-Alkoxy-propylenharnstoff-bzw. -thioharnstoffderivaten
CH449626A (de) Verfahren zur Herstellung von neuen Isoxazolderivaten
CH475270A (de) Verfahren zur Herstellung von neuen 5-Nitro-furyl-derivaten
CH457446A (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT263220B (de) Verfahren zur Herstellung von neuen Adenosin-derivaten
AT255412B (de) Verfahren zur Herstellung von neuen 3-Nitro-2-oxo-tetrahydroimidazolderivaten
AT266320B (de) Verfahren zur Herstellung von neuen Penicillinderivaten
CH455770A (de) Verfahren zur Herstellung von neuen Acridanderivaten
AT267059B (de) Verfahren zur Herstellung von neuen Penicillinen
AT275032B (de) Verfahren zur Herstellung von neuen Penicillinen
AT278240B (de) Verfahren zur Herstellung von neuen Penicillinen
CH457447A (de) Verfahren zur Herstellung von neuen Azepinderivaten
CH455791A (de) Verfahren zur Herstellung von neuen Azepinderivaten
CH454875A (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT275513B (de) Verfahren zur Herstellung von neuen Thiazolderivaten
CH451141A (de) Verfahren zur Herstellung von neuen 1-Hydroxy-piperidinderivaten
AT265254B (de) Verfahren zur Herstellung von neuen Rhodaninderivaten
AT277457B (de) Verfahren zur Herstellung von neuen Octopyranosiden
AT254904B (de) Verfahren zur Herstellung von neuen Aminoorganofluorosilikaten